Exhibit renderings. Credit: Museum of Medicine and Biomedical Discovery
They would move through the exhibit and see how the development of recombinant DNA “gene cloning” technology in the 1980s enabled large-scale production of an exact replica of human insulin. At the end of the exhibit, a second hologram of the same young girl would appear but now in the present day. She is strong and active, able to do all the things of a typical 10-year-old, thanks to the small glucose monitor and insulin pump she is wearing.
But that’s not the end of the story. Before visitors leave the exhibit, they will see and hear about the challenges that researchers are currently tackling to better understand the causes of, treatment for, and prevention of Type I diabetes. There are many other great stories that can and will be told in this exhibit using interactive technologies to make the stories compelling and memorable.
This is just one way to introduce visitors to a much larger, more complicated, and wondrous landscape.
Few people outside our profession realize how thrilling biomedical research can be. “The Magical Moments of Discovery” exhibit will enable researchers themselves to describe the moment when they saw the data from an experiment, the results of a clinical trial, or a patient in clinic and realized the field would be forever changed by this result. “How Do You Make That, Fix That, or Do That?” will showcase the impact of technology on science and medicine. This exhibit will provide a showcase for some of these advances, from the evolution of limb prostheses to robotic arms, to the impact of molecular biology on the creation of new classes of medicines, to how artificial intelligence is being applied to identify new drug targets and completely new classes of medicines, just to name a few.
These are just some of the exhibits and experiences that would be offered at the museum.
The museum will also address the problem of young people who feel that a career in science or medicine is simply unachievable. The “Why I Love What I Do” exhibitwill consist of a series of kiosks deployed throughout the museum. Interactive videos will enable individuals drawn from a wide array of backgrounds, ages, races, ethnicities, and accents to speak and interact directly with a visitor.
They will provide a virtual tour of their workplace, describing and showing visitors exactly what they do, how it advances knowledge or helps people heal, why they were drawn to the field in the first place, and why they love what they do.
Our goal is not just to educate and inform but to inspire visitors.
Exhibit renderings. Credit: Museum of Medicine and Biomedical Discovery
In just two years, with the help of a growing team of dedicated individuals, we have made significant progress toward bringing this museum from concept to reality. Receptions in several potential host cities have been met with tremendous enthusiasm and support for the museum.
We have engaged one of the world’s leading museum design firms to help us envision what a physical space would look like. We have begun work on creating a pop-up/traveling exhibit that will allow us to field test exhibits and kiosks and incorporate visitor feedback into designing the museum. Our goal is to have a pop-up museum ready by the end of 2025 and a bricks-and-mortar museum open before the decade is out.
Gaining the trust of a potentially skeptical audience will be a critical factor in our success and in restoring trust in science and medicine. One way of doing that is for the museum to be supported by individuals and foundations rather than commercial entities, especially those that may be seen as potentially benefiting from what is presented or how it’s presented. The Museum of Medicine is committed to being independent of commercial interests.
We realize that this is an ambitious goal. But the approaches currently being taken by industry, academia, and government haven’t been effective in stemming the erosion of trust in science and medicine. We cannot and should not let this continue unabated.
A new approach is needed, one that will create a place where every individual who visits the museum—either online, through a traveling exhibit, or by visiting the museum itself—will come away feeling “I know. I trust. I can imagine myself.”
To learn more about the Museum of Medicine and Biomedical Discovery, please visit our website.
Mace Rothenberg is CEO and president of the Museum of Medicine and Biomedical Discovery. A clinical and translational researcher in oncology, he had a 20-year career in academia at the NCI, the University of Texas Health Science Center at San Antonio, and Vanderbilt University Medical Center. He then moved to Pfizer where, over a 12-year career, Rothenberg was chief development officer for oncology and subsequently chief medical officer for the company. Rothenberg’s medical degree is from NYU Grossman School of Medicine.
Matteo Paz, 18, of Pasadena, CA, won the top award of $250,000 in the 2025 Regeneron Science Talent Search, the U.S.’s longest-running and most distinguished science, technology, engineering, and math competition for high school seniors (The Cancer Letter, March 7, 2025).
In this episode of In the Headlines, former NCI Director Kimryn Rathmell speaks with Paul Goldberg, publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, about the HHS layoffs and their potential impact on mental health. These layoffs—and the broader uncertainty introduced by the current administration’s actions—are a form of trauma, Rathmell says.
This column is a love letter of sorts to our field, a recognition of all that we have accomplished and an acknowledgement that we need to find a path forward that supports and empowers the best of what it is to invest in cancer research.
Colorectal cancer screening is an effective tool for catching the disease early when it’s most treatable, yet it is underutilized in patient populations who receive primary care at federally qualified health centers.
The NCI Cancer Center Support Grant requires community outreach and engagement, but the design and implementation of COE programs, as well as staff training, are largely left to individual institutions.
Kate Hitchcock, a UF Health radiation oncologist and an associate professor in the Department of Radiation Oncology in the UF College of Medicine, has been named associate director for access and opportunities at the UF Health Cancer Center. In this role, she will use her experience in leading clinical trials and broad range of healthcare experience to help the center train the next generation of cancer researchers, preparing them to lead advancements in the field.